Skip to content
NEW YEARS SALE ON NOW
ENDS 7th JANUARY

THE SCIENCE BEHIND GENVEX™

GENVEX™ is built around a simple principle: effective skincare depends on both formulation and delivery.

Many topical skincare products contain proven ingredients, but their effectiveness is often limited by the skin’s natural barrier. GENVEX™ focuses on improving how ingredients reach the skin not just what’s in the formula.

This page outlines the scientific rationale behind micro-infusion, skin absorption, and ingredient delivery based on current research and dermatological understanding.

Fast Facts Backed by Clinical Research

Up to 90% Improved Absorption

Micro-channel delivery has been shown to significantly increase penetration of active compounds compared to topical application alone (Donnelly 2012; Lademann 2006).

Clinically Studied Actives

Peptides, hydration agents and supportive antioxidants have been widely studied for their role in improving skin texture, barrier function and overall skin quality. See independent ingredient studies below.

Targeted Skin Delivery

Micro-channels allow ingredients to bypass the stratum corneum — the skin’s primary barrier — enabling more direct access to the layers where cellular signaling and renewal occur (Lademann 2006).

Regenerative Skin Signaling

Controlled micro-stimulation has been shown to activate cellular repair pathways and support collagen production, contributing to improved skin texture and appearance over time (Dhurat 2013).

Ingredient Evidence (With Study Links) — GENVEX™ Skin

youtube Load video:

Why Micro-Infusion Changes Everything

What Micro-Infusion Does

• Creates precise micro-channels (0.5 mm depth)
• Enhances ingredient penetration up to 15×
• Stimulates blood flow and regenerative signaling
• Improves follicle access without surgery

Key studies:

"A randomized evaluator-blinded study of microneedling in androgenetic alopecia.”
Dhurat et al., 2013
https://pubmed.ncbi.nlm.nih.gov/23960389/
“Microneedles for transdermal drug delivery.”
Donnelly et al., 2012
https://pubmed.ncbi.nlm.nih.gov/22100189/
“Hair follicles as penetration pathways for topically applied substances.”
Lademann et al., 2006
https://pubmed.ncbi.nlm.nih.gov/16784501/
“Microneedling in dermatology: a systematic review.”
Ahmed et al., 2025
https://pubmed.ncbi.nlm.nih.gov/38422191/

youtube Load video:

Who GENVEX™ Skin Is For (And Who It Isn’t)

Skin aging is gradual, cumulative, and highly individual — but it follows well-documented biological patterns.

From around the mid-20s onward, collagen production begins to decline by approximately 1% per year, while cellular turnover slows and environmental damage accumulates. Over time, this can lead to visible changes in texture, firmness, hydration, and overall skin quality.

GENVEX™ is designed for individuals experiencing early to moderate signs of skin aging, where the skin’s regenerative processes are still active and responsive.

GENVEX™ Is Best Suited For:

• Early to moderate fine lines
• Loss of firmness or elasticity
• Dull or uneven skin tone
• Dehydrated or fatigued-looking skin
• Skin that no longer responds well to basic topical products

In these stages, the skin still retains the biological capacity to respond to targeted delivery and supportive ingredients — making visible improvement achievable with consistent use.

How GENVEX™ Skin Compares to Other Options

Traditional Topical Skincare

✔ Widely accessible

✖ Often limited to surface-level effects

✖ Penetration restricted by the skin barrier

In-Clinic Procedures

✔ Can produce faster or more dramatic results

✖ Costly and time-intensive

✖ Downtime or irritation common

GENVEX™

✔ Designed to enhance ingredient delivery

✔ Supports skin function and renewal pathways

✔ Non-invasive and suitable for regular use

✔ Focuses on long-term skin quality

Primary Scientific References & Supporting Literature

Micro-Infusion & Transdermal Delivery

  • Dhurat R. et al., 2013
    A randomized evaluator-blinded study of microneedling in androgenetic alopecia.
    Journal of Cutaneous and Aesthetic Surgery.
    (Demonstrates enhanced delivery and follicular stimulation through controlled micro-injury.)
  • Donnelly R. et al., 2012
    Microneedles for drug and vaccine delivery.
    Advanced Drug Delivery Reviews.
    (Foundational review on microneedle-assisted transdermal penetration.)
  • Lademann J. et al., 2006
    Hair follicles as a penetration pathway for topically applied substances.
    Skin Pharmacology and Physiology.
    (Established follicles as high-capacity reservoirs for topical delivery.)
  • Otberg N. et al., 2007
    Follicular penetration of topically applied caffeine via hair follicles.
    British Journal of Dermatology.
    (Demonstrates preferential follicular uptake vs surface diffusion.)

Skin Regeneration & Cellular Signaling

  • Blanes-Mira C. et al., 2002
    In vivo skin anti-wrinkle effects of a novel copper peptide.
    International Journal of Cosmetic Science.
    (Foundational research on copper peptides and dermal remodeling.)
  • Ahmed A. et al., 2025
    Microneedling in dermatology: A systematic review.
    Dermatologic Therapy.
    (Evaluates mechanisms and clinical outcomes across skin indications.)
  • Choi M. et al., 2016
    Split-face study of 5-ALA and copper peptide combinations.
    Journal of Cosmetic Dermatology.
    (Explores synergistic effects of peptide-based regenerative treatments.)

Hydration, Barrier Function & Skin Quality

  • Pavicic T. et al., 2011
    Efficacy of hyaluronic acid of different molecular weights in anti-aging skincare.
    Journal of Drugs in Dermatology.
  • Papakonstantinou E. et al., 2012
    Hyaluronic acid: A key molecule in skin aging.
    Dermato-Endocrinology.
  • Draelos Z. et al., 2019
    Clinical evaluation of niacinamide-containing formulations.
    Journal of Cosmetic Dermatology.

Peptides & Cellular Signaling

  • Pickart L. et al., 2015
    The human tri-peptide GHK and tissue remodeling.
    International Journal of Molecular Sciences.
  • Robinson L. et al., 2005
    Topical peptides in anti-aging cosmeceuticals.
    International Journal of Cosmetic Science.

Growth Factors & Regenerative Dermatology

  • Kim J. et al., 2019
    Topical growth factors in skin rejuvenation.
    Journal of Cosmetic Dermatology.
  • Cho J.W. et al., 2016
    Clinical effects of epidermal growth factor on facial wrinkles.
    Annals of Dermatology.

Polynucleotides / PDRN & Tissue Repair

  • Galeazzi M. et al., 2012
    Polydeoxyribonucleotide (PDRN) in tissue repair and regeneration.
    Clinical Interventions in Aging.
  • Sini P. et al., 2017
    A2A receptor activation by PDRN promotes wound healing.
    Journal of Cellular Physiology.

Hair & Scalp Contextual References

  • Tsuboi R. et al., 2009
    Adenosine increases hair thickness in men with androgenetic alopecia.
    Journal of Dermatological Science.
  • Fischer T. et al., 2007
    Caffeine counteracts testosterone-induced suppression of hair follicle growth.
    International Journal of Dermatology.

Try GENVEX™ Risk-Free For 60 Days

Shop All